Compound from marine bacteria shows potential as multiple myeloma therapy
... I clinical trials in early 2006, say officials of nereus
Pharmaceuticals in San Diego, the developer of NPI...strong anticancer properties in laboratory tests. nereus
Pharmaceuticals holds an exclusive license to the ...el Palladino, Jr., PhD, chief technical officer of nereus
Pharmaceuticals, said that the company plans to f...
Nereus Pharmaceuticals Initiates ADVANCE, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer
... SAN DIEGO, March 23 /PRNewswire/ -- nereus
Pharmaceuticals, Inc., a pioneer in drug discovery...aid Matthew A. Spear, M.D., Chief Medical Officer, nereus
is also evaluating NPI-2358 in other solid tumor i...
Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
... SAN DIEGO, March 20 /PRNewswire/ -- nereus
Pharmaceuticals, Inc., a
pioneer in drug discovery...g agents," said Kobi
M. Sethna, President and CEO, nereus
Upon successful completion... of
the recommended doses for the combined agents, nereus
expects to advance
NPI-2358 into an international ...
Contract Services for Big Pharma and Biotechs Driving Growth and Innovation from Discovery to Clinical Trials
-- Partha S. Ray, MD, CEO, IndusPharma Consulting Group
-- Michael Palladino, PhD, Senior VP, CTO, & Scientific Co-Founder, nereus
-- Steve J. Bannister, PhD, Chief Scientific Officer, Xcelience, LLC
-- Judd Berman, PhD., Chief Scientific Officer, Dalton Me...